NASALCARE

Live / Registered — Registered and renewed (as of 07 Jan 2020)

What this means for you

Registered since 29 Sept 2009. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 29 Sept 2019).

Record

Serial number
77504998
Registration number
3688173
Mark type
Design + words
Filed
22 Jun 2008
Published for opposition
20 Jan 2009
Registered
29 Sept 2009
Next maintenance due
29 Sept 2019

Goods and services

  • Class 005 — Pharmaceuticals: [ Analgesic and muscle relaxant pharmaceutical preparations; Anti-diabetic pharmaceuticals; ] Antibacterial pharmaceuticals; [ Antimicrobial preparations for inhibiting microbiological decomposition in food, beverages, animal feed and pharmaceuticals; ] [ Antimicrobial preservatives for cosmetics and pharmaceuticals; ] [ Astringents; Bismuth preparations for pharmaceutical purposes; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; ] Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; [ Drug delivery agents in the form of a coating for macromolecule agents that facilitate the delivery of a wide range of pharmaceuticals; Gelatin capsules sold empty for pharmaceuticals; ] Homeopathic pharmaceuticals for use in the treatment of allergy and respiratory tract infections; [ Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Inhalers filled with anti-infectives and anti-allergy pharmaceuticals; ] [ Injectable pharmaceuticals for treatment of anaphylactic reactions; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Ocular pharmaceuticals; Pharmaceutical anti-allergic preparations and substances; ] Pharmaceutical antitussive-cold preparations; [ Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; ] Pharmaceutical preparations and substances for the treatment of infectious diseases, [ blood disorders, ] pain, inflammation [, sepsis, alopecia, obesity and cognitive disorders ] ; [ Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; ] Pharmaceutical preparations for the prevention and treatment of [ ocular disorders or diseases, for the treatment of ] bacteria-based diseases, [ and for the treatment of diabetes, ] and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations [ and vaccines ] ; [ Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; ] Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; [ Pharmaceutical preparations for treating diabetes; ] Pharmaceutical preparations for use in chemotherapy; [ Pharmaceutical preparations for use in urology; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of joint disease; ] Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; [ Pharmaceutical solutions used in dialysis; Pharmaceuticals for the treatment of erectile dysfunction; ] Pharmaceuticals, namely, anti-infectives; [ Pharmaceuticals, namely, antihelmintics; ] [ Pharmaceuticals, namely, inducers of erections; Pharmaceuticals, namely, lipid lowering agents; Plant extracts for medical, veterinary and pharmaceutical purposes; ] [ Potassium preparations for pharmaceutical purposes; ] [ Radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use; Synthetic peptides for pharmaceutical purposes; Unit dose capsules sold empty for pharmaceutical use; Vitamin and mineral preparations for use as ingredients in the food and pharmaceutical industry; Yeast or yeast extracts for medical, veterinary or pharmaceutical purposes ]

Owner

Prosecution history

  • 07 Jan 2020 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
  • 07 Jan 2020 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
  • 07 Jan 2020 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
  • 06 Jan 2020 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
  • 03 Jan 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 07 Jul 2019 — POST REGISTRATION ACTION MAILED - SEC. 8 & 9
  • 07 Jul 2019 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
  • 21 Jun 2019 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 21 Jun 2019 — TEAS SECTION 8 & 9 RECEIVED
  • 29 Sept 2018 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
  • 12 Oct 2016 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
  • 12 Oct 2016 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
  • 28 Sept 2016 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
  • 27 Sept 2016 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
  • 06 Jun 2016 — TEAS CHANGE OF CORRESPONDENCE RECEIVED

View this trademark record on Marksy